Primary structure of cat preproendothelin-2 and cat renal mRNA expression of preproendothelin-1 and preproendothelin-2 in naturally occurring renal failure

Experimental Biology and Medicine

Volumn 231, Issue 6, 2006, Pages 997-1000

  Uchide, Tsuyoshi ^a   Saida, Kaname ^b  

^a KITASATO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Cat kidney; Chronic renal failure; ET 1; ET 2

Indexed keywords

MESSENGER RNA; PREPROENDOTHELIN; PREPROENDOTHELIN 1; PREPROENDOTHELIN 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; CONFERENCE PAPER; KIDNEY FAILURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CAT DISEASES; CATS; CONSERVED SEQUENCE; DNA, COMPLEMENTARY; ENDOTHELIN-1; ENDOTHELINS; KIDNEY FAILURE, CHRONIC; MOLECULAR SEQUENCE DATA; PROTEIN PRECURSORS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

CANIS FAMILIARIS; EQUUS CABALLUS; FELIDAE; MUSTELA PUTORIUS FURO; ORYCTOLAGUS CUNICULUS;

EID: 33744915260     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Schmetterer L, Dallinger S, Bobr B, Selenko N, Eichler HG, Wolzt M. Systemic and renal effects of an ET(A) receptor subtype-specific antagonist in healthy subjects. Br J Pharmacol 124:930-934, 1998.
2. Herman WH, Emancipator SN, Rhoten RL, Simonson MS. Vascular and glomerular expression of endothelin-1 in normal human kidney. Am J Physiol 275:F8-17, 1998.
3. Harris PJ, Zhuo J, Mendelsohn FA, Skinner SL. Haemodynamic and renal tubular effects of low doses of endothelin in anaesthetized rats. J Physiol 433:25-39, 1991.
4. Gomez-Garre D, Ruiz-Ortega M, Ortego M, Largo R, Lopez-Armada MJ, Plaza JJ, Gonzalez E, Egido J. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27:885-892, 1996.
5. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78:225-228, 1989.
6. Simonson MS, Wann S, Mene P, Dubyak GR, Kester M, Nakazato Y, Sedor JR, Dunn MJ. Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 83:708-712, 1989.
7. Sorokin A, Kohan DE. Physiology and pathology of endothelin-1 in renal mesangium. Am J Physiol Renal Physiol 285:F579-589, 2003.
8. Ohta K, Hirata Y, Shichiri M, Kanno K, Emori T, Tomita K, Marumo F. Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int 39:307-311, 1991.
9. Koyama H, Tabata T, Nishzawa Y, Inoue T, Morii H, Yamaji T. Plasma endothelin levels in patients with uraemia. Lancet 8645:991-992, 1989.
10. Ohkubo S, Ogi K, Hosoya M, Matsumoto H, Suzuki N, Kimura C, Ondo H, Fujino M. Specific expression of human endothelin-2 (ET-2) gene in a renal adenocarcinoma cell line. Molecular cloning of cDNA encoding the precursor of ET-2 and its characterization. FEBS Lett 274: 136-140, 1990.
11. Saida K, Mitsui Y. cDNA cloning, sequence analysis and tissue distribution of a precursor for vasoactive intestinal contractor (VIC). Biochim Biophys Acta 1089:404-406, 1991.
12. Uchide T, Fujimori Y, Temma K, Sasaki T, Saida K Cloning of bovine preproendothelin-2 cDNA and organ distribution of transcripts. DNA Seq 14:385-392, 2003.
13. Deng AY. Structure and organization of the rat endothelin-2 gene. Mamm Genome 8:157, 1997.
14. Fujimori Y, Uchide T, Saida K, Temma K, Sasaki T, Akera T. Cloning of full-length preproendothelin-2 cDNA and its expression in dog. J Vet Med Sci 65:1217-1225, 2003.
15. Uchide T, Fujimori Y, Sasaki T, Temma K, Lee YS, Saida K. cDNA and deduced amino acid sequences of ferret preproendothelin-2 and phylogenetic analysis. DNA Seq 13:369-374, 2002.
16. Uchide T, Fujimori Y, Temma K, Sasaki T, Kizaki K, Hara Y, Takizawa S, Saida K cDNA cloning, sequence analysis and organ distribution of horse preproendothelin-2. J Cardiovasc Pharmacol 44: S430-434, 2004.
17. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988.
18. Saida K, Kometani N, Masuda H, Oka S, Uchide T. Structure of mouse preproendothelin-3 and phylogenetic analysis of the endothelins. J Cardiovasc Pharmacol 36:S1-4, 2000.
19. Wolf SC, Smoltczyk H, Brehm BR, Erley CM, Risler T. Endothelin-1 and endothelin-3 levels in different types of glomerulonephritis. J Cardiovasc Pharmacol 31:S482-485, 1998.
20. Vlachojannis JG, Tsakas S, Petropoulou C, Goumenos DS, Alexandri S. Endothelin-1 in the kidney and urine of patients with glomerular disease and proteinuria. Clin Nephrol 58:337-343, 2002.
21. Hocher B, Liefeldt L, Thone-Reineke C, Orzechowski HD, Distler A, Bauer C, Paul M. Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene. Hypertension 28:196-201, 1996.